Shawn David Roman - 11 Jun 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Chief Operating Officer
Issuer ticker: APYX
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 19:00:07 UTC
Prior SEC filing: 29 Jan 2026
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Shawn Roman

Key filing fact

Shawn David Roman filed Form 4 for Apyx Medical Corp (APYX) on 15 Jun 2026.

Key facts

This page summarizes Shawn David Roman's Form 4 filing for Apyx Medical Corp (APYX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 19:00.

Change

Previous filing in this sequence was filed on 29 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002048672 Primary reporting owner

Roman Shawn David

Relationship: Chief Operating Officer
Address: C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
Signature: /s/ Shawn Roman
Signature date: 15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock Option (Option to Buy)

Award

Transaction value
Shares: +88,044
Change %
Price: $0.000000^*
Shares after: 88,044
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 88,044
Exercise price: $4.65
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.